UK's National Health Service Bans Puberty Blockers for Minors

The chapter delves into the UK's National Health Service's stance on banning puberty-blocking drugs for minors, citing concerns about safety and reversibility. The speaker applauds the UK government for prioritizing children's well-being and looks towards the potential impact on transgender care in the US.